Two programmes get the most clicks on Business Chain after HF0: a16z Speedrun and PearX. Founders treat them as interchangeable because both write six and seven figure cheques to early companies. They are not interchangeable. One is closed right now. The other takes applications today. That single fact should decide where you spend this week, not next year.
What the cheque actually buys
a16z Speedrun invests up to $1,000,000 and has deployed more than $180,000,000 to over 200 startups since 2023. That cheque buys you a fixed residency program built around that capital: you are one of a cohort moving through a structured timeline together, not a founder negotiating a bespoke deal. The next residency, SR008, runs February 1 to April 16, 2027 in San Francisco. The equity question here is set by the program terms attached to that cheque, not by you.
PearX writes $500,000 to $2,000,000, a wider band that tells you something: Pear is sizing the cheque to the company in front of them, not to a program template. PearX runs two cohorts a year, winter and summer, and takes applications year round, which means the equity conversation happens as a negotiation on your specific terms rather than a fixed slot in a batch. If you want capital that flexes to your cap table, that is the structural difference, not a marketing line.
Stage expectation is the real filter
a16z Speedrun's math, $180M across 200+ companies since 2023, works out to roughly $900,000 average per company, close to its stated cap of $1M. A program writing near-max cheques to that many companies in that timeframe is not hunting for raw ideas. It wants a company already moving: product live, some signal, a team that can absorb a seven figure cheque and compress months of work into a 2027 residency window. PearX's $500K-$2M range, open year round rather than locked to one cohort date, is built to catch companies earlier, including ones still finding product market fit. If you don't have traction yet, PearX's door is the one that's actually built for you. Speedrun's isn't, regardless of whether applications were open.
One is closed. Act on that this month.
a16z Speedrun's intake is not open right now. SR008 runs February 1 to April 16, 2027, which means an application sent today has nowhere to go until that window opens. Spending this month polishing a Speedrun application is spending it on a program that cannot read it yet.
PearX is accepting applications today, with no cohort gate blocking submission. For a founder with a live product and a funding gap now, that is the cheque to chase this month, and the $500K-$2M range gives you room to negotiate against your actual valuation instead of a fixed template. Put the Speedrun application on your calendar for later. Put the PearX one in front of you now.
If neither one fits your stage
Not every company is ready for a $500K-$2M negotiated cheque or a $1M program cheque tied to a 2027 start date. The catalogue has 42 programmes that invest for equity beyond these two, and 89 that are grants taking no equity at all. A few examples from the catalogue, with the terms exactly as published:
- FSF Accelerator Grant: $50,000, no equity, run by the Fashion Scholarship Fund.
- Google for Startups Accelerator: equity-free mentorship and technical support, no cash cheque attached.
- Alchemist Accelerator: $25,000 stipend for roughly 5% equity, negotiable.
- Michigan Business Accelerator Fund: $7,000 to $15,000, a much smaller cheque for a much earlier stage.
- GSF Accelerator: seed investment plus mentorship, run by GSF India.
If you're still deciding between taking equity capital at all versus a grant that takes none, the full list of 42 equity programmes is worth a direct look at businesschain.us/funds/type/equity before you commit an application to either Speedrun or PearX. The right programme is the one whose terms match where your company actually is this month, not the one with the biggest name attached to it.
